Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
From Educational Loans to Obligation Free: Independence from the rat race Accomplished - 25 Superstar Couples That Motivate Relationship Objectives
- 3Poland identifies two Ukrainian suspects in railway sabotage blast
- 4Vote in favor of your Favored sort of footwear
- 5This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself.
- I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
- 6 Fun Urban areas For Seniors To Travel
- The Main 15 Applications for Efficiency and Association
- 4 African Vacationer Locations
- What are parents to do as doctors clash with Trump administration over vaccines?
- The Appearance of Experience: Embracing the Reduced Portage Horse
- 'All Her Fault' ending explained: The shocking conclusion to the psychological thriller inspired by true events
- Step by step instructions to Pick the Right Web-based Degree Program
- Remain Fit and Sound with These Exercise Fundamentals
